Chagas disease centennial anniversary celebration: historical overview and prospective proposals aiming to maintain vector control and improve patient prognosis -a permanent challenge
Furthermore, recognition of the epidemiological importance of sylvatic and semi-domiciliated vectors indicates the requirement for permanent surveillance in order to avoid the resurgence of acute Chagas disease in our territory (Coura 2007 , Guhl et al. 2009 , Lazzari & Lorenzo 2009 ).
In summary, it is time to commemorate both the unique features in the science and medicinal history of Carlos Chagas and the currently successful main vector control and decline of new acute cases, as described above. However, it is imperative to remember that we still face other challenges, including the following urgent needs:
(i) to develop strategies for maintaining sustainable and integrated surveillance in areas that display diverse epidemiological patterns, allowing the identification of priority areas for intervention;
(ii) to guarantee patients adequate global care and access to available therapies; (iii) to improve the diagnostic tools for early (parasitological, serological) diagnosis of the infection; (iv) to identify and validate prognostic markers for disease progress to support rational interventions; (v) to design and search for new selective prophylactic and therapeutic tools, based on T. cruzi and/or human genomic and proteomic information, guaranteeing their assessment in clinical studies, as well as identifying new options (i.e., low costs, oral applications, protective against widespread isolates of the parasites etc.) that are effective during the chronic phase (in the case of a trypanocidal drug) with low toxicity to the patient and (vi) to support research aimed increasing our knowledge regarding the biochemical, biological and molecular maincreasing our knowledge regarding the biochemical, biological and molecular maregarding the biochemical, biological and molecular machinery involved in host/parasite interactions and the pathophysiological mechanisms operating in disease progression. This would allow the generation of new approaches, including cell therapy, immunoregulation and vaccines, targeted at interrupting disease development.
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